Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREA LYNN DELAIRE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1669082830
CMS profile
10710593
Location
HARTFORD, CT

General Payments · PY2021–2024

$1,544.41

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$349.19

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $349.19 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $90.54 4
BAXTER HEALTHCARE $51.75 2
Acerta Pharma LLC $45.51 2
NOVARTIS PHARMACEUTICALS CORPORATION $39.76 2
E.R. Squibb & Sons, L.L.C. $35.26 1
Amgen Inc. $31.36 1
Medtronic, Inc. $28.87 1
PFIZER INC. $26.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $283.01 14
PY2022 $14.62 1
PY2023 $897.59 50
PY2024 $349.19 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $31.36 10/14/2024 Food and Beverage Undisputed 01/23/2026 1115561928 CMS
AstraZeneca Pharmaceuticals LP $24.75 04/25/2024 Food and Beverage Undisputed 01/23/2026 1105664686 CMS
AstraZeneca Pharmaceuticals LP $20.76 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104711423 CMS
Baxter Healthcare $35.10 09/19/2024 Food and Beverage Undisputed 01/23/2026 1118299430 CMS
Baxter Healthcare $16.65 09/24/2024 Food and Beverage Undisputed 01/23/2026 1118299432 CMS
E.R. Squibb & Sons, L.L.C. $35.26 10/15/2024 Food and Beverage Undisputed 01/23/2026 1101424476 CMS
Medtronic, Inc. $28.87 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116975649 CMS
Novartis Pharmaceuticals Corporation $16.95 01/03/2024 Food and Beverage Undisputed 01/23/2026 1086933063 CMS
Novartis Pharmaceuticals Corporation $22.81 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086933069 CMS
Novo Nordisk Inc $20.88 03/06/2024 Food and Beverage Undisputed 01/23/2026 1100393360 CMS
Novo Nordisk Inc $22.46 04/03/2024 Food and Beverage Undisputed 01/23/2026 1100318012 CMS
Novo Nordisk Inc $24.25 09/11/2024 Food and Beverage Undisputed 01/23/2026 1100442249 CMS
Novo Nordisk Inc $22.95 10/29/2024 Food and Beverage Undisputed 01/23/2026 1100537702 CMS
PFIZER INC. $26.14 07/10/2024 Food and Beverage Undisputed 01/23/2026 1131831692 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.